Ribeiro-Dantas, M.d.C.; Oliveira Imparato, D.; Dalmolin, M.G.S.; de Farias, C.B.; Brunetto, A.T.; da Cunha Jaeger, M.; Roesler, R.; Sinigaglia, M.; Siqueira Dalmolin, R.J.
Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis. Cancers 2021, 13, 1860.
https://doi.org/10.3390/cancers13081860
AMA Style
Ribeiro-Dantas MdC, Oliveira Imparato D, Dalmolin MGS, de Farias CB, Brunetto AT, da Cunha Jaeger M, Roesler R, Sinigaglia M, Siqueira Dalmolin RJ.
Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis. Cancers. 2021; 13(8):1860.
https://doi.org/10.3390/cancers13081860
Chicago/Turabian Style
Ribeiro-Dantas, Marcel da Câmara, Danilo Oliveira Imparato, Matheus Gibeke Siqueira Dalmolin, Caroline Brunetto de Farias, André Tesainer Brunetto, Mariane da Cunha Jaeger, Rafael Roesler, Marialva Sinigaglia, and Rodrigo Juliani Siqueira Dalmolin.
2021. "Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis" Cancers 13, no. 8: 1860.
https://doi.org/10.3390/cancers13081860
APA Style
Ribeiro-Dantas, M. d. C., Oliveira Imparato, D., Dalmolin, M. G. S., de Farias, C. B., Brunetto, A. T., da Cunha Jaeger, M., Roesler, R., Sinigaglia, M., & Siqueira Dalmolin, R. J.
(2021). Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis. Cancers, 13(8), 1860.
https://doi.org/10.3390/cancers13081860